Advicenne Contact

Facebook Share Twitter Share LinkedIn Share Pinterest Share Reddit Share E-Mail Share

Listing Results Advicenne Contact

3 hours ago Sur cette page, vous pouvez facilement contacter le bureau d'Advicenne pour les relations avec les investisseurs ou les demandes de renseignements généraux. About us. Our Story; Leadership; Board of Directors; contact our medical information service by phone: France +33 434481199

Preview / Show more

See Also: Business PortalShow details

2 hours ago For more than 10 years, Advicenne has been dedicated to developing innovative, effective and safe treatments for people living with rare renal diseases who have very limited therapeutic …

Preview / Show more

See Also: Business PortalShow details

6 hours ago Contact. Numéro de téléphone 24/7 selon la région At Advicenne we are dedicated to improving patients’ daily health and life. Our employees in France and the United States are …

Preview / Show more

See Also: Business PortalShow details

9 hours ago Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases. Search Crunchbase. Start Free Trial . Chrome …

Founder: Caroline Roussel-Maupetit, Luc Andre Granier
Founded: Jul 01, 2007

Preview / Show more

See Also: Company Show details

3 hours ago Find company research, competitor information, contact details & financial data for ADVICENNE of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet. D&B …

Preview / Show more

See Also: Company Show details

3 hours ago Find company research, competitor information, contact details & financial data for ADVICENNE of MONTBONNOT ST MARTIN, AUVERGNE RHONE ALPES. Get the latest business …

Preview / Show more

See Also: Company Show details

4 hours ago Advicenne Profile and History . Advicenne (Euronext: ADVIC) is a pharmaceutical company founded in 2007, specializing in the development of innovative treatments in Nephrology. Its …

Preview / Show more

See Also: Company Show details

6 hours ago Advicenne has 32 employees across 3 locations and €2.06 M in annual revenue in FY 2020. See insights on Advicenne including office locations, competitors, revenue, …

Preview / Show more

See Also: Company Show details

6 hours ago Advicenne Inc. is the US arm of Advicenne S.A., a Publicly traded French pharmaceutical Company developing Pathbreaking treatments for rare diseases. Our focus in the US is the …

Preview / Show more

See Also: Business PortalShow details

7 hours ago Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and …

Preview / Show more

See Also: Company Show details

9 hours ago PARIS, September 14, 2022--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company …

Preview / Show more

See Also: Business PortalShow details

1 hours ago 1:45 PM - 2:00 PM (PDT), Wednesday, June 15, 2022. At Advicenne we are committed to developing a robust, valuable, and sustainable portfolio of products that address …

Preview / Show more

See Also: Business PortalShow details

Just Now Company profile page for Advicenne SACA including stock price, company news, press releases, executives, board members, and contact information

Preview / Show more

See Also: Company Show details

All Time (13 Tips) Past 24 Hours Past Week Past monthFacebook Share Twitter Share LinkedIn Share Pinterest Share Reddit Share E-Mail Share

Please leave your comments here:

New Categories

Frequently Asked Questions

Who is advicenne?

Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria.

Why has advicenne withdrawn its submission to nice?

In England, Advicenne has withdrawn its submission to the National Institute for Health and Care Excellence (NICE). The current absence of long-term outcome data for dRTA patients precluded a robust health economic model to be provided to NICE.

When will my message be forwarded to the relevant advice ni team?

Your message will be forwarded to the relevant Advice NI team and someone will respond to you within 3 working days. To find out how we process your data, please see our Privacy Policy.

Most Popular Search

App
Ascom
Alko